Niloofar Rahmani

Array ( [id] => 177949 [patent_doc_number] => 07655657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Fused bicycloheterocycle substituted quinuclidine derivatives' [patent_app_type] => utility [patent_app_number] => 11/789949 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 43606 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655657.pdf [firstpage_image] =>[orig_patent_app_number] => 11789949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113666 [patent_doc_number] => 20070197582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'IMIDAZO[[1, 5-A] PYRIDINE DERIVATIVES AND METHODS FOR TREATING ALDOSTERONE MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/739290 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9707 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197582.pdf [firstpage_image] =>[orig_patent_app_number] => 11739290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441812 [patent_doc_number] => 20090093451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'IL-8 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/297885 [patent_app_country] => US [patent_app_date] => 2007-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16956 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093451.pdf [firstpage_image] =>[orig_patent_app_number] => 12297885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225646 [patent_doc_number] => 20070254913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Phosphodiesterase 4 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/785741 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51980 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254913.pdf [firstpage_image] =>[orig_patent_app_number] => 11785741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281854 [patent_doc_number] => 07553854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => '6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling' [patent_app_type] => utility [patent_app_number] => 11/737069 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72974 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553854.pdf [firstpage_image] =>[orig_patent_app_number] => 11737069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178056 [patent_doc_number] => 20070179116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Fused Pentacyclic Polyethers' [patent_app_type] => utility [patent_app_number] => 11/733601 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11258 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179116.pdf [firstpage_image] =>[orig_patent_app_number] => 11733601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7595440 [patent_doc_number] => 07626021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Fused ring heterocycle kinase modulators' [patent_app_type] => utility [patent_app_number] => 11/733753 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 73814 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626021.pdf [firstpage_image] =>[orig_patent_app_number] => 11733753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687305 [patent_doc_number] => 20090176986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Process for the Preparation of Pyridine Heterocycle Cgrp Antagonist Intermediate' [patent_app_type] => utility [patent_app_number] => 12/226126 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12238 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176986.pdf [firstpage_image] =>[orig_patent_app_number] => 12226126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724346 [patent_doc_number] => 08097617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 12/295549 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41193 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097617.pdf [firstpage_image] =>[orig_patent_app_number] => 12295549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225644 [patent_doc_number] => 20070254911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators' [patent_app_type] => utility [patent_app_number] => 11/690429 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18436 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254911.pdf [firstpage_image] =>[orig_patent_app_number] => 11690429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550730 [patent_doc_number] => 08063063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Immunopotentiating compounds' [patent_app_type] => utility [patent_app_number] => 12/294237 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41601 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063063.pdf [firstpage_image] =>[orig_patent_app_number] => 12294237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5540023 [patent_doc_number] => 20090221828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Process for Preparing 1-Halo-2,7-Naphthyridinyl Derivatives' [patent_app_type] => utility [patent_app_number] => 12/293202 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7892 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221828.pdf [firstpage_image] =>[orig_patent_app_number] => 12293202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4978004 [patent_doc_number] => 20070219237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Chromane Derivatives' [patent_app_type] => utility [patent_app_number] => 11/687781 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26334 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219237.pdf [firstpage_image] =>[orig_patent_app_number] => 11687781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691446 [patent_doc_number] => 20070232587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Homotropanes with central nervous system activity' [patent_app_type] => utility [patent_app_number] => 11/716816 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13979 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232587.pdf [firstpage_image] =>[orig_patent_app_number] => 11716816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602613 [patent_doc_number] => 07432376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Tropane prodrugs with central nervous system activity' [patent_app_type] => utility [patent_app_number] => 11/716817 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1843 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432376.pdf [firstpage_image] =>[orig_patent_app_number] => 11716817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199749 [patent_doc_number] => 20070299067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/716307 [patent_app_country] => US [patent_app_date] => 2007-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23081 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299067.pdf [firstpage_image] =>[orig_patent_app_number] => 11716307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131788 [patent_doc_number] => 20070208185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Intermediates for the hemisynthesis of taxanes and preparation processes therefor' [patent_app_type] => utility [patent_app_number] => 11/714817 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14719 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208185.pdf [firstpage_image] =>[orig_patent_app_number] => 11714817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211602 [patent_doc_number] => 07622508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => '8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/711961 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 57282 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622508.pdf [firstpage_image] =>[orig_patent_app_number] => 11711961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005606 [patent_doc_number] => 20070203178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'CRYSTALLINE SOLVATES OF APIXABAN' [patent_app_type] => utility [patent_app_number] => 11/678206 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5582 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203178.pdf [firstpage_image] =>[orig_patent_app_number] => 11678206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522031 [patent_doc_number] => 20090030012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 12/223556 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18288 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030012.pdf [firstpage_image] =>[orig_patent_app_number] => 12223556 [rel_patent_id] =>[rel_patent_doc_number] =>)